Synapse - Dmitriy Zamarin

Results (24)

Pattern of disease and response to pembrolizumab in recurrent cervical cancer

Journal Article

Miller, K. M.; Filippova, O. T.; Hayes, S. A.; Abu-Rustum, N. R.; Aghajanian, C.; Broach, V.; Ellenson, L. H.; Selenica, P.; Jewell, E. L.; Kyi, C.; more...
Gynecologic Oncology Reports (2021)

Fulltext@MSK | Save

Pattern of disease in recurrent cervical cancer associated with response to pembrolizumab

Meeting Abstract

Miller, K.; Filippova, O. T.; Hayes, S. A.; Abu-Rustum, N.; Aghajanian, C.; Broach, V.; Ellenson, L. H.; Jewell, E. L.; Kyi, C.; Lakhman, Y.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent high-grade and low-grade serous ovarian cancer

Meeting Abstract

Grisham, R. N.; Giri, D. D.; McDonnell, A.; Iasonos, A.; Zhou, Q.; Li, K.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Aghajanian, C.
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Circulating cell-free DNA in patients with newly diagnosed and recurrent cervical cancer

Meeting Abstract

Kim, S. H.; Wu, M.; Stylianou, A.; Ghafoor, S.; Lakhman, Y.; Park, K. J.; Leitao, M. M. Jr; Sonoda, Y.; Gardner, G. J.; Broach, V.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers

Journal Article

Veeraraghavan, H.; Friedman, C. F.; DeLair, D. F.; Ninčević, J.; Himoto, Y.; Bruni, S. G.; Cappello, G.; Petkovska, I.; Nougaret, S.; Nikolovski, I.; more...
Scientific Reports (2020)

Fulltext@MSK | Save

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: A phase II trial

Journal Article

Zamarin, D.; Walderich, S.; Holland, A.; Zhou, Q.; Iasonos, A. E.; Torrisi, J. M.; Merghoub, T.; Chesebrough, L. F.; Mcdonnell, A. S.; Gallagher, J. M.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

PD-1 blockade in advanced adrenocortical carcinoma

Meeting Abstract

Raj, N.; Zheng, Y.; Kelly, V.; Katz, S.; Chou, J.; Do, R.; Capanu, M.; Zamarin, D.; Saltz, L.; Ariyan, C.; more...
Pancreas (2020)

Fulltext@MSK | Save

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer

Journal Article

Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Boucicaut, N. N.; Henson, M.; Iasonos, A.; Zhou, Q.; Sarasohn, D. M.; Gallagher, J.; Kravetz, S.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save

PD-1 blockade in advanced adrenocortical carcinoma

Journal Article

Raj, N.; Zheng, Y.; Kelly, V.; Katz, S. S.; Chou, J.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Saltz, L. B.; Ariyan, C. E.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Computed tomography-derived radiomic metrics can identify responders to immunotherapy in ovarian cancer

Journal Article

Himoto, Y.; Veeraraghavan, H.; Zheng, J.; Zamarin, D.; Snyder, A.; Capanu, M.; Nougaret, S.; Vargas, H. A.; Shitano, F.; Callahan, M.; more...
JCO Precision Oncology (2019)

Fulltext@MSK | Save